Intercell AG: Losses Doubled, Positive Outlook

Business › n.a. ♦ Published: November 9, 2010; 16:10 ♦ (Vindobona)

Today, Vienna-based Intercell AG announced its financial results for the third quarter of 2010 and presented changes to the Management Board.

Intercell AG: Losses Doubled, Positive Outlook / Picture: © Intercell

Intercell's aggregate revenues decreased by 28.4% from € 29.5m in the 9 months ended September 30, 2009 to € 21.1m in the same period of 2010.

Net loss for the first nine months of 2010 increased to € 50.9m mainly driven by increased R&D expenses for late stage development programs and non-cash currency effects. For the whole year 2010, Intercell expects to record net…

or Log In

Fast News Search
Related News
Unexpected Rise in Research Expenditure (November 4, 2010)
Intercell AG - publication pursuant to Sections 4 and 5 of the Publication Ordinance (July 21, 2010)
Intercell reports Phase II Study Results of its Vaccine Enhancement Patch for Pandemic Influenza (July 2, 2010)
Intercell AG -Resolutions of the AGM (June 28, 2010)
Intercell AG - Hospital bug vaccine delayed (May 18, 2010)
Read More
Pharmaceutical Industry, Intercell, Vaccines, Earnings, Medicine
Featured
See latest Vindobona Newsletter